History
  • No items yet
midpage
425 F.Supp.3d 336
D.N.J.
2019
Read the full case

Background

  • Austar International and Dr. Rong Liu formed AustarPharma (a New Jersey LLC) as a joint venture; Austar International financed the company and Liu served as CEO and a director. The operating agreement included restrictive covenants and board/consent thresholds.
  • AustarInternational alleges that in or about 2013 Liu founded/controlled Bostal (a Chinese company), used AustarPharma’s proprietary drug‑delivery technologies, hired AustarPharma personnel, and diverted corporate opportunities and contracts to Bostal.
  • AustarInternational filed suit in D.N.J. asserting derivative and direct claims: breach of fiduciary duty, breach of operating agreement, conversion, DTSA (federal), NJTSA (state), tortious interference, and a statutory judicial‑expulsion claim.
  • Defendants moved to dismiss (Rule 12(b)(6)) and AustarPharma separately moved to dismiss on adequacy grounds (Fed. R. Civ. P. 23.1). Defendants later sought dismissal or a stay in favor of a parallel suit in China.
  • The court denied dismissal of the DTSA and NJTSA claims and of tortious‑interference and derivative claims (finding demand‑futility adequately pled), granted dismissal of the conversion claim (failure to plead tangible property), upheld personal jurisdiction over Bostal under Calder, and denied a comity‑based stay/dismissal without prejudice.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Derivative standing / Rule 23.1 (demand & adequacy) Austar Int'l is the only realistic representative of the minority class; demand on AustarPharma would be futile because Liu controls a blocking majority and the board Austar Int'l is conflicted, blended individual/derivative claims, and failed to plead a particularized pre‑suit demand Court: AustarInt'l adequately pled demand futility and adequacy under Rule 23.1; derivative claims may proceed
DTSA and NJTSA (trade secrets pleading) Complaint identifies AustarPharma’s proprietary drug‑delivery technologies, alleges confidentiality measures and facts supporting misappropriation Defendants: allegations are conclusory, fail to identify specific trade secrets or protective steps and lack misappropriation details Court: Pleading meets Twombly/Iqbal plausibility; DTSA and NJTSA claims survive dismissal
Conversion (Count III) Austar Int'l alleges defendants converted corporate funds, personnel and trade assets Defendants: conversion requires tangible property; people and intangible trade secrets are not recoverable via conversion Court: Conversion claim dismissed (Rule 12(b)(6)) for failure to plead conversion of tangible property; dismissal without prejudice to amend
Personal jurisdiction over Bostal (Calder effects test) Bostal, via Liu, targeted AustarPharma (NJ HQ): appropriated NJ‑based technology and employees; harm was felt in NJ Bostal: acts occurred in China, no specific intent to target NJ, not registered in NJ Court: Specific jurisdiction satisfied under Calder (intentional tort aimed at NJ; focal point of harm in NJ); 12(b)(2) denied
International comity / parallel China suit Austar Int'l: US DTSA claim and US contract issues require US forum; Chinese suit will not fully resolve US claims Defendants: nearly identical claims pending in China; comity favors deferral or dismissal in favor of Chinese forum Court: Actions not entirely parallel (DTSA and other US remedies); no extraordinary circumstances to stay or dismiss; comity request denied without prejudice

Key Cases Cited

  • Vanderbilt v. Geo-Energy Ltd., 725 F.2d 204 (3d Cir. 1984) (standards for adequacy of derivative representative)
  • In re Merck & Co., Inc. Sec., Derivative & ERISA Litig., 493 F.3d 393 (3d Cir. 2007) (demand‑futility and business‑judgment considerations)
  • Somportex Ltd. v. Philadelphia Chewing Gum Corp., 453 F.2d 435 (3d Cir. 1971) (international comity principles)
  • Keeton v. Hustler Magazine, Inc., 465 U.S. 770 (U.S. 1984) (personal jurisdiction principles for torts)
  • Calder v. Jones, 465 U.S. 783 (U.S. 1984) (‘effects’ test for jurisdiction over intentional torts aimed at forum)
  • Daimler AG v. Bauman, 571 U.S. 117 (U.S. 2014) (limits on general jurisdiction)
  • Bell Atlantic Corp. v. Twombly, 550 U.S. 544 (U.S. 2007) (pleading must be plausible)
  • Ashcroft v. Iqbal, 556 U.S. 662 (U.S. 2009) (pleading standard for facial plausibility)
Read the full case

Case Details

Case Name: AUSTAR INTERNATIONAL LIMITED v. AUSTARPHARMA LLC
Court Name: District Court, D. New Jersey
Date Published: Nov 27, 2019
Citations: 425 F.Supp.3d 336; 2:19-cv-08356
Docket Number: 2:19-cv-08356
Court Abbreviation: D.N.J.
Log In
    AUSTAR INTERNATIONAL LIMITED v. AUSTARPHARMA LLC, 425 F.Supp.3d 336